Clinical Instructor in Population Medicine, HVMA, Boston
Internal Medicine
Dr. Calvin J. Cohen, MD
|
|
Give Review
Calvin Cohen is an expert in the field of Internal Medicine. He graduated from Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School has a rank of 1 in research and a 12 in primary care He received 11 awards: "Patient-Centered Medical Home Recognition Program", "Physician Practice Connections Recognition Program", "CMS Meaningful Use Stage 1 Certification", "The Robert H. Ebert Teaching Award", "Community Recognition", "Outstanding Physicians", "Champions of the Search", "Distinction for Research in Cardioiogy", "Aipha Omega Alpha", "Upjohn Award for Exceilence in Medical Training" and "Quill and Dagger Honor Society". Calvin Cohen is a published doctor. He has 29 papers published. The most current publication "Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir..." Calvin J. Cohen, MD is registered with Medicare.
Publications
- Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir...
- Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate i...
- A randomized, double-blind comparison of single tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single tablet regimen efavirenz/emtricitabine/...
- Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials.
- A randomized, double-blind comparison of co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF for initial treat...
- Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infect...
- Relationship between plasma protease inhibitor concentrations and lipid elevations in HIV patients on a double-boosted protease inhibitor regimen (saquinavir/lopinavir...
- Select updates from the 16th CROI: treatment-related cardiovascular risk, pharmacokinetic issues, and interleukin-2 use.
- Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial.
- Antiretroviral therapy update from the 48th ICAAC/46th IDSA annual meeting.
- Update on antiretroviral therapy: the 15th CROI.
- Advances in HIV therapeutics: news from the 4th International AIDS Society Conference.
- Use of Dronabinol Improves Appetite and Reverses Weight Loss in HIV/AIDS-Infected Patients.
- Advances in HIV therapeutics: the 14th CROI.
- Recent developments in HIV therapeutics.
- Editorial comment: impact of darunavir for salvage therapy.
- Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study.
- XVI International AIDS Conference: Part 2.
- XVI International AIDS Conference: Part 1.
- Successful HIV treatment: lessons learned.
- Ritonavir-boosted protease inhibitors, Part 2: cardiac implications of lipid alterations.
- Ritonavir-boosted protease inhibitors, Part 1: strategies for balancing efficacy with effects on lipids.
- Antiretroviral therapy: the "when to start" debates.
- Health-related quality of life with enfuvirtide (ENF; T-20) in combination with an optimized background regimen.
- Antiretroviral rounds. First holiday was a disaster: should she take another?
- Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.
- Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid populat...
- Efficacy and safety 48 weeks after switching from efavirenz to rilpivirine using emtricitabine/tenofovir disoproxil fumarate-based single-tablet regimens.
Schools
Albert Einstein College of Medicine of Yeshiva University
Beth Israel Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Patient-Centered Medical Home Recognition Program
- Physician Practice Connections Recognition Program
- CMS Meaningful Use Stage 1 Certification
- The Robert H. Ebert Teaching Award
- Community Recognition
- Outstanding Physicians
- Champions of the Search
- Distinction for Research in Cardioiogy
- Aipha Omega Alpha
- Upjohn Award for Exceilence in Medical Training
- Quill and Dagger Honor Society
Education
-
Harvard Medical School -
Beth Israel Deaconess Medical Center -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Beth Israel Deaconess Medical Center -
Newton-Wellesley Hospital -
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1063484426 | |
| NPPES Provider LastName | COHEN | |
| NPPES Provider FirstName | CALVIN | |
| NPPES Provider ZIPCode | 022153904 | |
| NPPES Provider State | MA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 3503.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 106.0 | |
| Percent Opioid Claims | 3.03 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063484426 |
| Last Name Of The Provider | COHEN |
| First Name Of The Provider | CALVIN |
| View All |
Similar Doctors
|
|
Dr. Colleen M. Keyes, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naimish R. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura C. Myers, MD |
|
|
Dr. Sounok Sen, MD |
|
|
Dr. Lindsay W. Cole, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alessandra Calvo-Friedman, MD |
|
|
Dr. Michael J. Tierney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen H. Romansky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanhee A. Chung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary Ellen J. Goldhamer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nivedita Ghosh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nina A. Chalfin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. P R. Larsen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Eirini Pectasides, MD |
|
|
Dr. Elizabeth A. Mort, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neha Ohri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Weijia Wang
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julian Lel, MD
This Doctor is OpenDoctor Recommended.
|